|
|
||||||||
| ABSTRACT |
|
|
|---|
| INTRODUCTION |
|
|
|---|
In a previous report5 with C6/36 cells, a cell line derived from Aedes albopictus larvae,6 we showed that virus particles of DENV type 4 (DENV4) bind to two glycoproteins of 40 kD (gp40) and 45 kD (gp45) present on the cell surface. Additionally, polyclonal antibodies directed against gp45 were able to block virus binding and a cytopathic effect. Antibodies to gp40/45 detected a 45-kD protein present in different development mosquito stages and in permissive tissues of Ae. aegypti mosquitoes,7 which suggested that gp45 is present in susceptible tissues in mosquitoes and is part of a receptor complex for DENV in mosquito cells. Unfortunately, although we have been isolated this protein by affinity chromatography using the envelope (E) protein as a receptor, the identification of gp45 has been unsuccessful.
Several heat-shock proteins (HSPs) have been implicated as receptors for viruses such as coxsackie and rotavirus with their host cells.8–10 Specifically for DENV, HSP90 (84 kD) and HSP70 (72 kD) have been described as part of DENV receptor complex in human monocytes-macrophages and in promonocytic (U937) and neuroblastoma (SH-SY-5Y) human cell lines.11 The glucose-regulated protein GRP 78 (BiP) was identified as part of DENV receptor complex in the human hepatoma cell line HepG2.12 However, the effect of stress conditions such as heat shock on virus entry is unknown.
In most organisms, the cellular stress response is characterized by an increase in synthesis and/or relocation of HSPs. Under physiologic conditions, HSPs are expressed at low levels.13 However, a wide variety of stressful stimuli including environmental, pathologic, or physiologic factors induce a marked increase in HSP synthesis14 known as the stress response. Because some putative receptors for DENV in mammalian cells are HSPs, which are highly conserved molecules in mammalian and mosquito cells, the role of heat shock in DENV infection in C6/36 cells was evaluated.
| MATERIALS AND METHODS |
|
|
|---|
Affinity chromatography and immunoblots. Total protein extracts from C6/36 cells were obtained as previously described11 and passed through a NiNTA resin (Qiagen, Valencia, CA) coupled to a recombinant DENV E protein following the procedure previously reported.17 Briefly, 2 mg of total protein from C6/36 cells were passed over an affinity column that consisted of full length DENV-4 recombinant E protein immobilized by its amino-terminal His-tag to an NiNTA resin (Qiagen). After extensive washing with interaction buffer (50 mM NaH2PO4, 200 mM NaCl, 1% Triton X-100, pH 8) the DENV receptor molecules were eluted with high ionic strength buffer (50 mM NaH2PO4, 500 mM NaCl, pH 8). The eluted molecules were concentrated in a Centricon 10 centrifuge microconcentrator (Amicon, Beverly, MA) and analyzed by sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) and stained with Coomasie blue. The 45-kD band was excised and digested with trypsin. The peptides were subjected to by matrix-assisted laser desorption/ionization time of flight (MALDI-ToF) analysis at the Protein Core Laboratory Facility (Columbia University, New York, NY). Edman N-terminal sequencing of the protein was also performed.
The elution fraction was analyzed by Western blot assays using a monoclonal antibody to HSP90 diluted 1:20,000 (SPA-830; Stressgen Biotechnologies, Victoria, British Columbia, Canada), a polyclonal antibody to gp45 diluted 1:10,000,5 and a monoclonal antibody to HSP70 diluted 1:5,000 (MA3-007; Affinity Bioreagents, Golden, CO). An anti-mouse horseradish peroxidase (HRP)–conjugated antibody (Amersham, Piscataway, NJ) diluted 1:30,000 were used as a secondary antibody. Briefly, 20 µL or 60 µg of either elution fractions or total protein extracts from C6/36 cells were subjected to a SDS-PAGE on a 10% gel (Mini PROTEAN System; Bio-Rad Laboratories, Hercules, CA) and transferred to a nitro-cellulose membrane by using a semidry blotting apparatus (Bio-Rad Laboratories) with 48 mM Tris, 39 mM glycine, 20% (v/v) methanol. Transfer efficiency was monitored by staining with 0.1% Ponceau red in 7% trichloracetic acid. The membrane was blocked with low-fat milk for 1 hour at 37°C with gentle shaking and then incubated for 1 hour at 37°C with primary antibody diluted in phosphate-buffered saline (PBS), 0.5% Tween 20. The membrane was washed three times with PBS, 0.5% Tween 20 and incubated for 1 hour at 37°C with the secondary antibody diluted in PBS, 0.5% Tween 20. After exhaustive washing with PBS, 0.5% Tween 20, the reaction was developed using a chemiluminescence kit (Supersignal West Femto Maximum Sensitivity Substrate; Pierce, Rockford, IL) according to the manufacturers protocol and X-OMAT film (Eastman Kodak, Rochester, NY).
Heat-shock treatment and detection of gp45. Monolayers of C6/36 cells were incubated at 35°C or heat-shocked at 41°C for 1 or 3 hours. The culture medium was then removed, cells were resuspended in PBS, transferred to a 1.5-mL microcentrifuge vials, and centrifuged in a microcentrifuge (5417R; Eppendorf, Hamburg, Germany) at 61.6 x g for 6 minutes at room temperature. Cells were then fixed with PBS, 4% paraformaldehyde for 1 hour at room temperature and then blocked with 100% fetal bovine serum overnight at 4°C. The cells were then washed once with washing buffer (PBS, 2% fetal bovine serum) at room temperature, centrifuged as described above, and incubated for 1 hour at room temperature with a mouse polyclonal antibody to gp45 diluted 1:50 in washing buffer. The cells were then washed three times and incubated with an anti-mouse FITC-conjugated antibody (Zymed, South San Francisco, CA) diluted 1:50 in washing buffer as secondary antibody. Finally, the cells were washed three times, resuspended in 0.5 mL of PBS, 1% paraformaldehyde, 2% fetal bovine serum, and analyzed by flow cytometry in a FACScalibur apparatus (Becton Dickinson, Franklin Lakes, NJ).
Immunoprecipitation assay. C6/36 cells incubated at 35°C or heat-shocked at 41°C were labeled with 100 µg of biotin 3 sulfo-N-hydroxisuccimide (Sigma, St. Louis, MO) per 2 x 106 cells for 1 hour at room temperature. After washing with PBS, the cells were homogenized and the total protein extract was obtained as described previously.11 Thirty micrograms of each protein extract was incubated with 5 µL of polyclonal antibody to gp45 and 15 µL of agarose-coupled G protein (Sigma) overnight at 4°C with gentle shaking. After four washing steps (10 minutes per wash) with TNT buffer (20 mM Tris-HCl, 300 mM NaCl, 0.1% Triton X-100, pH 7.2), the proteins bound were eluted with 200 mM glycine (Sigma), pH 2, for 2 minutes at room temperature, subjected to SDS-PAGE, and transferred to a nitrocellulose membrane. The membrane was blocked overnight at 4°C with 4% fetal calf serum in PBS with gentle shaking. Finally, the membrane was incubated with strepatavidin-HRP (Amersham) diluted 1:500,000 in PBS, 1% Tween 20 for 1 hour at room temperature, washed three times with PBS, 1% Tween 20, and developed with chemiluminescence (Supersignal West Femto Maximum Sensitivity Substrate-Pierce).
Virus overlay protein binding assay (VOPBA). C6/36 cells were cultured in 60 cm-diameter culture dishes (Corning, Corning, NY) overnight. The monolayers were washed with culture medium and subjected to heat shock at 41°C for 1 or 3 hours. Cells were then incubated for 1 hour at 35°C. One of the dishes was incubated at 35°C and used as a control. Total protein extracts from cells were obtained and used in VOPBA as previously described.11
Virus binding assay. Binding of DENV to C6/36 cells was assayed by flow cytometry following the procedure reported by Triantafilou and Triantafilou18 with some modifications. Briefly, C6/36 cells were placed in two 24-well plates (3 x 105 cells/well) and incubated at 35°C in culture medium. One of the plates was then incubated at 41°C for 1 hour and the other was incubated at 35°C. After heat shock, the cells treated were incubated for 1 hour at 35°C. Culture medium was removed, PBS, 4% paraformaldehyde was added, and the plates were incubated at room temperature for 30 minutes. The monolayers were washed twice with binding buffer (PBS, 0.5% fetal bovine serum) and incubated with DENV-2 diluted in binding buffer at a multiplicity of infection (MOI) of 0.1 for 2 hours at room temperature with gentle shaking. The monolayers were washed twice with binding buffer, re-fixed as described above, washed twice with washing buffer, and blocked with fetal bovine serum overnight at 4°C. The cells were washed once with washing buffer and incubated with monoclonal antibody to DENV-2 (Chemicon, Temecula, CA) diluted 1:100 in washing buffer for 1 hour at room temperature. Subsequent to three washes, the monolayers were incubated with an anti-mouse FITC-conjugated antibody (Zymed) diluted 1:200 in washing buffer for 1 hour at room temperature with gentle shaking. Finally the cells were washed three times with washing buffer and then detached using PBS, 1% paraformaldehyde, 2% fetal bovine serum buffer and transferred to 1.5-mL microcentrifuge vials. Samples were analyzed by flow cytometry in a FACScalibur cytometer (Becton Dickinson).
Dengue virus infection assay. C6/36 cells were cultured in 25-cm2 culture flasks (Corning). One flask was incubated at 35°C and then infected, and the other was subjected to heat shock for 1 hour at 41°C and then infected with DENV-2 at an MOI of 0.1 for 40 minutes at 35°C with gentle shaking. Virus was then removed and the cells were washed once with culture medium. Forty-eight hours later, the supernatants were recovered and virus titer was determined by plaque assay.
Virus titration. BHK-21 cells were seeded in a 24-well plates (2 x 105 cells/well) with 0.5 mL of culture medium/well. C6/36 infected cell supernatants were serially diluted and 50 µL of the inoculum was incubated on BHK-21 cells for 4 hours at 37°C. Afterwards, 0.5 mL of the overlay medium was added (2x MEM supplemented with non-essential amino acids, 3% carboxymethyl cellulose, 10% fetal calf serum, penicillin, and streptomycin). The cultures were incubated for 6 days at 37°C and then counted for plaque formation after fixation with 10% formalin and staining with 0.5% naphthol-blue-black (Sigma) in 165 mM sodium acetate, 6% acetic acid solution.
Confocal microscopy. Cells grown on coverslips were left untreated or heat-shock treated for 1 hour. The cells were then washed with PBS, fixed with 4% of paraformaldehyde for 1 hour, and washed and incubated with the blocking solution (PBS, 10% fetal bovine serum) for 1 hour at room temperature. After this treatment, cells were washed and incubated overnight at 4°C with the mouse anti-gp45 antibody diluted 1:50. Cells were washed and incubated with FITC-conjugated anti-mouse IgG 1:80 (Zymed) for 1 hour at room temperature. After a washing step, nuclei were stained with propidium iodide solution (Sigma). Slides were mounted with Vectashield® (Vector Laboratories, Burlingame, CA) and analyzed using a Leica (Wetzlar, Germany) TCS SP2 confocal microscope.
| RESULTS |
|
|
|---|
(EF1
), a G protein of the arthopod Lithophane hemina. The amino terminal sequence of the 45-kD protein was obtained and a Basic Local Alignment Search Tool (BLAST) analysis was performed with the obtained amino acid sequence [XEK(Q/T)LNADQ(D/G/A)V(G/L)K(E/A)(Y/G)RL]. This analysis showed that the amino acids residues EKQLNAD are present and highly conserved in the amino terminal of several G proteins from nematodes. These data suggest that the 45-kD protein may be a G protein. However, additional studies are required to identify this protein.
To further characterize the proteins in the elution fraction from the affinity chromatography column, these fractions were subjected to SDS-PAGE and analyzed by Western blot assay using monoclonal antibodies against HSP90 and HSP70, the two proteins identified as part of DENV receptor complex in monocytes.11 Antibody to gp45 was used as a control. As was previously reported,17 gp45 was detected in the elution fraction (Figure 1A
, lane 1), which corroborated that virus particles and recombinant E protein attached to the column are able to interact with the same group of molecules. A commercial monoclonal antibody to HSP90 detected two proteins in the elution fraction, gp45 and an additional protein of 74-kD (p74) (Figure 1A
, lane 2). This finding suggested that gp45 and p74 may share an epitope with human HSP90. The epitope for this antibody was mapped between amino acids 604 and 697 in human HSP90.19 Conversely, the monoclonal antibody to HSP70 did not detect any band in the elution fraction (Figure 1A
, lane 3), although it recognized a band of approximately 70 kD in total protein extracts from C6/36 cells and BHK-21 cells (Figure 1B
).
|
To corroborate that gp45 and heat-shock–induced p74 are able to interact with the virus particle, a VOPBA was performed. Dengue 2 virus bound to gp45, as well as to 60-, 74-, and 80-kD proteins in untreated and heat-shock–treated cells (Figure 2
, lanes 1–3). However, the amount of virus bound to the 74-kD protein was markedly increased in the extract from cells heat-shocked for 3 hours (Figure 2
, lane 3). Proteins with similar molecular weights have also been detected in the four DENV serotypes, C6/36 cell extracts, and mosquito tissue extracts by the same approach.20
|
|
To further support our conclusion, the location of gp45 and p74 was analyzed by confocal microscopy using non-permeabilized cells and antibody to gp45. In untreated cells, a punctuate arrangement of the proteins on the cell surface was observed (Figure 3C
), and a patched distribution was detected on heat-shock–treated cells (Figure 3D
). Thus, the distribution and arrangement of the proteins on the cell surface is modified after heat-shock treatment. Our data suggest that under normal conditions gp45 and p74 are present on the cell surface, and after heat-shock treatment their amounts on the cell surface increase and they acquire a patch distribution.
Effect of heat shock on DENV binding to the cell surface.
Our previous studies indicated that gp45 is involved in DENV infection because antibodies against this protein inhibited DENV binding and infection in a dose-dependent manner.5,7 The gp45 and p74 proteins may be required for DENV binding and/or entry. We took advantage of their higher amounts on the cell surface in heat-shock–treated cells and analyzed their role in both steps. Because a 1-hour heat-shock treatment increases the amount of gp45 and p74 on the cell surface, we analyzed DENV binding in untreated cells and in cells heat-shocked for 1 hour. The amount of virus bound under these conditions was determined in paraform-aldehyde-fixed non-permeabilized cells by flow cytometry.8 The results showed that DENV 2 bound to the cell surface more efficiently after heat-shock treatment than under normal conditions (Figure 4
), which suggested that a higher virus binding efficiency correlated with the increase of gp45 and p74 on the cell surface.
|
|
| DISCUSSION |
|
|
|---|
Our group has characterized two glycoproteins of 40 and 45 kD (gp40 and gp45) as part of DENV receptor complex in C6/36 cells.5 We showed that antibodies directed against gp45 can inhibit DENV binding to C6/36 cells and that semipurified protein gp45 could compete with C6/36 cells for virus binding. Moreover, antibodies against gp45 inhibit DENV infection. We showed that gp45 in mosquito tissues correlated with susceptibility to DENV infection7, which supports the idea that gp45 plays an important role in DENV infection. Our group and other investigators have purified putative receptors from mosquito cells or tissues; however, the role of these receptors has not been identified.
We have used amino terminal sequencing and mass spectrometry of tryptic peptides by MALDI-ToF analysis to investigate purified proteins. Eight of 16 amino terminal amino acids have homology with those of several G proteins. Additionally, four peptides obtained by MALDI-ToF analysis correspond to the GTP binding domain from a G protein. The G proteins have important functions as receptors, as well as signals transducers, and these functions are compatible with a virus-binding and/or receptor protein.24 Although these findings suggest that the gp45 is a G protein, further analysis, including mass spectroscopy, must be conducted to identify this protein.
Because some HSPs such as HSP90, HSP70, and GRP 78 have been implicated in the first interaction between DENV and host cells,11,12 we analyzed the role of HSPs in mosquito cells, as well as a possible relationship between gp45 and HSP. Proteins from C6/36 cells with affinity to DENV E protein were isolated by affinity chromatography and analyzed by Western blot with human antibodies to HSP90 and HSP70.17 Monoclonal antibody to HSP90 detected gp45 and a 74-kD protein from the elution fraction. The epitope recognized by the antibody has been mapped between amino acids 604 and 697 in the C-terminal domain of human HSP90. This domain is important in HSP90 because it is involved in dimerization and binds to tetratricopeptide repeat co-chaperones.25 The amino acid sequence recognized by the antibody was used to find a similar sequence in a mosquito protein database. Although we found some open reading frames and proteins whose sequences could be similar to the one detected by the antibodies, additional experiments are required to identify them.
The fact that p74 is recognized by a monoclonal antibody against HSP90 and is induced and relocated to the cell surface after heat shock is consistent with the idea that p74 could be an HSP. Conversely, gp45, which was also recognized by the monoclonal antibody against HSP90, was not induced by heat shock. However, it was relocated to the cell surface after heat-shock treatment, which suggests that gp45 could also be a heat-shock–related protein. Heat shock and other stress conditions can induce production and relocation of different HSPs.26–28 Several inducible and non-inducible HSPs in mosquito cells have similar molecular weights to the proteins described in this work.29
The C6/36 cells used in this study were adapted to grow at 35°C.16 This temperature is 7°C warmer than conventional growth temperatures (28°C). Although these cells may be in a permanent heat-shocked state, this is not the case because they were gradually adapted and can still respond to stress conditions. Over-expression of stress proteins such as p74 was observed when the cells were heat-shocked.
We have demonstrated that antibodies against gp45 could inhibit DENV binding and infection. In this study, we showed that gp45 and p74, which bind to E protein, relocate to the cell surface and this relocation correlates with an increase in virus binding after heat-shock treatment. These results indicate that gp45 and p74 function as attachment molecules, probably concentrating DENV particles at the cell surface to allow efficient interaction with an as yet unidentified entry factor. However, we were unable to detect an increase in the amount of virus after heat-shock treatment. Because the amount of virus is the result of serial events that include adequate virus attachment, entry, translation, replication, and morphogenesis, enhanced viral attachment after heat-shock treatment may not be necessary for an increase in the amount of virus. Moreover, we cannot rule out the possibility that HSPs induced after heat-shock treatment might function as regulators in translation, replication, or morphogenesis of dengue virus. Because susceptibility to other virus infections such as Chinkunkunya virus was observed under heat shock in mosquitoes,30 it would be interesting to analyze the effect of heat shock in susceptibility to DENV.
The role of HSPs in different steps of the virus replicative cycle in host cells suggests that stress conditions may regulate viral synthesis.31–38 The ability of p74 to interact with the E recombinant protein from DENV and its relocation to the cell surface by heat shock suggests that this protein may play a role in DENV binding. This proposal is currently being analyzed. Thus, HSPs may be involved in virus infection, pathogenesis, immune response, and tropism.
Received July 9, 2006. Accepted for publication April 27, 2007.
Acknowledgments: We thank Matilde García Espitia and Fernando Medina for technical assistance, Victor Hugo Reynoso for assistance with flow cytometric analysis, and Ivan Galván for assistance with confocal microscopy.
Financial support: This work was supported by a fellowship from Comisión de Operación y Fomento de Actividades Académicas of the Instituto Politénico Nacional (IPN) to Juan Salas-Benito, and from Consejo Nacional de Ciencia y Tecnología (39946-Q) and Secretaría de Investigación y Posgrado-IPN (CGPI 20050605). Jorge Reyes del Valle was supported by a scholarship from the National Researcher System.
* Address correspondence to Juan Salas-Benito, Programa Institucional de Biomedicina Molecular, Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, Guillermo Massieu Helguera #239, Frac. la Escalera Ticomán, Mexico City, Mexico. E-mail: e-mail: jsalasb{at}yahoo.com ![]()
Authors addresses: Juan Salas-Benito and Mariana Salas-Benito, Programa Institucional de Biomedicina Molecular, Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, Guillermo Massieu Helguera #239 Frac. La Escalera Ticomán. Mexico City, Mexico CP 07320, Telephone: 52-55-57-29-6000 extension 55536, E-mail: jsalasb{at}yahoo.com. Jorge Reyes-Del Valle, Molecular Medicine Program, Mayo Clinic College of Medicine, Rochester, MN, 55905. Ivonne Ceballos-Olvera, Clemente Mosso, and Rosa M. del Angel, Departamento de Patología Experimental, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Av. Instituto Politécnico Nacional, #2508 Col. San Pedro Zacatenco, Mexico City, Mexico, CP 07360, Telephone: 52-55-5061-3800 extension 5647.
| REFERENCES |
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |